Name of Patient : Mr.

HEERA BHATT Test Request ID : 30272509120003

Age/Gender : 60 Yrs/Male Specimen Drawn ON : 12-Sep-2025 09:34AM
Collected AT : NAAGRAJA DIAGNOSTICS Specimen Received ON : 12-Sep-2025 09:35AM
Referred BY : Dr. self Report DATE : 12-Sep-2025 02:42PM
Sample Type : [Link] - F - SEP10947,Serum - SEP10945, - ,EDTA Blood - SEP10946
Ref Customer :

CRL SWASTHYA CARE

BIOCHEMISTRY
Test Name Result Biological Reference Method
Range
GLUCOSE FASTING
Glucose Fasting 108.0 70.0 - 110.0 mg/dL HEXOKINASE
Interpretation (In accordance with the American diabetes association guidelines):
· A fasting plasma glucose level below 110 mg/dL is considered normal.
· A fasting plasma glucose level between 100‑126 mg/dL is considered as glucose intolerant or pre diabetic. A fasting and post‑prandial blood sugar
test (after consumption of 75 gm of glucose) is recommended for all such patients.
· A fasting plasma glucose level of above 126 mg/dL is highly suggestive of a diabetic state. A repeat fasting test is strongly recommended for all such
patients. A fasting plasma glucose level in excess of 126 mg/dL on both the occasions is confirmatory of a diabetic state.
.

EGFR (ESTIMATED GLOMERULAR FILTRATION RATE)

Creatinine 2.20 mg/dL Spectrophotometry
Blood Urea Nitrogen (BUN) 31.7 6.00-20.0 mg/dl Spectro-photometry
Albumin 4.19 3.50-5.0 g/dL
Gfr By MdRd 32.60 mL/min/1.73 m2 Spectrophotometric -
Calculated
COMMENT-The Kidney Disease Improving Global Outcomes (KDIGO) guideline defines CKD by the presence of glomerular filtration
rate (GFR) <60 mL/min/1.73m2 for >3 months and/or evidence of kidney damage (eg, structural abnormalities, histologic abnormalities,
albuminuria, urinary sediment abnormalities, renal tubular disorders, and/or history of kidney transplantation) for >3months.2 Thus,
monitoring should include tests for GFR, albuminuria, and urine sediment.
CLINICAL USE-
• Detect chronic kidney disease (CKD) in adults.
• Monitor CKD therapy and/or progression in adults.
Interpretation of eGFR Values
eGFR (mL/min/1.73m2 ) Interpretation
90 Normal
60-89 Mild decrease
45-59 Mild to moderate decrease
30-44 Moderate to severe decrease
15-29 Severe decrease
<15 Kidney failure

QR CODE

. Page 1 of 11
 Name of Patient : Mr. HEERA BHATT Test Request ID : 30272509120003
Age/Gender : 60 Yrs/Male Specimen Drawn ON : 12-Sep-2025 09:34AM
Collected AT : NAAGRAJA DIAGNOSTICS Specimen Received ON : 12-Sep-2025 09:35AM
Referred BY : Dr. self Report DATE : 12-Sep-2025 11:01AM
Sample Type : [Link] - F - SEP10947,Serum - SEP10945, - ,EDTA Blood - SEP10946
Ref Customer :

Test Name Result Biological Reference Method

Range
LIVER FUNCTION TEST (LFT)-EXTENDED
Bilirubin Total 0.68 <1.1 mg/dl Diazotized Sulfanilic
Bilirubin Direct 0.22 0-0.3 mg/dl Diazotized Sulfanilic
Bilirubin Indirect 0.48 0.3-1.0 mg/dl Diazotized Sulfanilic
SGOT (AST) 23.6 <31.0 U/L IFCC without pyridoxal
phosphate
SGPT (ALT) 33.0 <33.0 U/L IFCC without pyridoxal
phosphate
Alkaline Phosphatase (ALP) 104.0 40-129 U/L Kinetic Colour
Gamma Glutamyl Transferase (GGT) 70.6 15-60 U/L L-Gamma-glutamyl-3-
carboxy-4-nitroanilide
Substrat
Protein Total 6.98 6.6-8.7 g/dL Biuret
Albumin (Serum) 4.19 3.5-5.5 g/dL Bromo Cresol Green
(BCG)
Globulin 2.79 2.50-3.50 g/dL Calculated
A/G Ratio 1.50 1.5-2.5 Calculated
Interpretation:- Liver blood tests, or liver function tests, are used to detect and diagnose disease or inflammation of the liver. Elevated
aminotransferase (ALT, AST) levels are measured as well as alkaline phosphatase, albumin, and bilirubin. Some diseases that cause abnormal levels
of ALT and AST include hepatitis A, B, and C, cirrhosis, iron overload, and Tylenol liver damage. Medications also cause elevated liver enzymes. There
are less common conditions and diseases that also cause elevated liver enzyme levels.: Liver blood tests, or liver function tests, are used to detect and
diagnose disease or inflammation of the liver. Elevated aminotransferase (ALT, AST) levels are measured as well as alkaline phosphatase, albumin,
and bilirubin. Some diseases that cause abnormal levels of ALT and AST include hepatitis A, B, and C, cirrhosis, iron overload, and Tylenol liver
damage. Medications also cause elevated liver [Link] are less common conditions and diseases that also cause elevated liver enzyme levels.

QR CODE

. Page 2 of 11
 Name of Patient : Mr. HEERA BHATT Test Request ID : 30272509120003
Age/Gender : 60 Yrs/Male Specimen Drawn ON : 12-Sep-2025 09:34AM
Collected AT : NAAGRAJA DIAGNOSTICS Specimen Received ON : 12-Sep-2025 09:35AM
Referred BY : Dr. self Report DATE : 12-Sep-2025 11:01AM
Sample Type : [Link] - F - SEP10947,Serum - SEP10945, - ,EDTA Blood - SEP10946
Ref Customer :

Test Name Result Biological Reference Method

Range
LIPID PROFILE BASIC
Total Cholesterol 103.0 <200.00 mg/dL mg/dL Enzymatic Colorimetric
Triglyceride 280.0 0.0-150 :Normal Enzymatic Colorimetric
151-199:Border Line >=200 :
High
200.0-499.0 High
> 500 Very High mg/dl
HDL Cholesterol 41.6 40-60 mg/dL Direct (PVS/PEGME
precipitation & Trinder
reaction)
Non HDL Cholesterol 61.40 Calculated
LDL Cholesterol 5.40 0-130 :Normal Direct (PVS/PEGME
131-155:Borderline precipitation & Trinder
>=160 :High mg/dl reaction)
VLDL Cholesterol 56.0 2.00-30.00 mg/dL Calculated
Cholesterol/HDL Ratio 2.48 <4.00 Calculated
LDL / HDL Cholestrol Ratio 0.13 <3.50 Calculated
HDL/LDL Cholesterol Ratio 7.70 <3.50 Calculated
Total Cholesterol (mg/dL) <200 – Desirable 200‑239 ‑Borderline high <240 – High
HDL Cholesterol (mg/dL), <40 – Low >60 – High
LDL Cholesterol (mg/dL) <100 Optimal
[Primary Target of Therapy] 100-129 Near optimal /above optimal, 130-159 Borderline high,160-189 High,>190 Very [Link] Triglycerides
(mg/dL) <150 Normal,150-199 Borderline high,200-499 High,>500 Very high
NCEP recommends lowering of LDL Cholesterol as the primary therapeutic target with lipid lowering agents, however, if triglycerides remain >200
mg/dL after LDL goal is Reached, seti secondary goal for non-HDL cholesterol (total minus HDL) 30 mg/dL higher than LDL goal.
Risk Category LDL Goal (mg/dL) Non-HDL Goal (mg/dL)
CHD and CHD Risk Equivalent <100 <130
(10-year risk for CHD>20%)
Multiple (2+) Risk Factors and <130 <160
10-year risk <20%
0-1 Risk Factor <160 <190

QR CODE

. Page 3 of 11
 Name of Patient : Mr. HEERA BHATT Test Request ID : 30272509120003
Age/Gender : 60 Yrs/Male Specimen Drawn ON : 12-Sep-2025 09:34AM
Collected AT : NAAGRAJA DIAGNOSTICS Specimen Received ON : 12-Sep-2025 09:35AM
Referred BY : Dr. self Report DATE : 12-Sep-2025 11:01AM
Sample Type : [Link] - F - SEP10947,Serum - SEP10945, - ,EDTA Blood - SEP10946
Ref Customer :

Test Name Result Biological Reference Method

Range
IRON PROFILE BASIC
Iron, Serum 92.3 59-158 ug/dL Colorimetric

Comment-
Iron is an essential trace mineral element which forms an important component of hemoglobin, metallocompounds and Vitamin A. Deficiency of iron,
leads to microcytic hypochromic anemia. The toxic effects of iron are deposition of iron in various organs of the body and hemochromatosis.

Increases in serum iron level are associated with the following:

Idiopathic hemochromatosis, Liver necrosis ( viral hepatitis), Hemosiderosis caused by excessive iron intake (eg, multiple transfusions, excess iron
administration,)Acute iron poisoning (children), Hemolytic anemia, Pernicious anemia, Aplastic or hypoplastic anemia, Lead poisoning, Thalassemia,
Vitamin B6 deficiency, Estrogens, Ethanol, Oral contraceptive

Decreases in the serum iron level are associated with the following:
Iron deficiency anemia, Nephrotic syndrome (loss of iron-binding proteins), Chronic renal failure, Chronic infections, Active hematopoiesis,
Remission of pernicious anemia, Hypothyroidism, Malignancy (carcinoma), Postoperative state, Kwashiorkor

NOTE-If patients with iron deficiency anemia receive iron medication before blood is drawn, normal or high concentrations are typically
noted. Even multivitamins with low (18 mg) elemental iron may produce this result. Thus, 24 hours before a blood draw for serum iron,
all oral iron mediation should be stopped. Parenteral injection of iron dextran may result in high serum iron levels (eg, 500‑1000 µg/dL)
for several [Link] of sodium ferric gluconate or iron sucrose causes increases in iron levels that last much shorter.
Recent transfusions influence test findings.

Total Iron​ Binding Capacity-(TIBC) 338.0 250-400 ug/dL Spectro-photometry

Transferrin Saturation 27.31 16-50 %
Total iron-binding capacity
The test measures the extent to which iron-binding sites in the serum can be saturated. Because the iron-binding sites in the serum are
almost entirely dependent on circulating transferrin, this is really an indirect measurement of the amount of transferrin in the blood.
Taken together with serum iron and percent transferrin saturation clinicians usually perform this test when they are concerned about
anemia, iron deficiency or iron deficiency anemia. However, because the liver produces transferrin, liver function must be considered when
performing this test. It can also be an indirect test of liver function, but is rarely used for this purpose

Transferrin Saturation
1g of transferrin can carry 1.43g of iron. Normally, iron saturation of transferrin (transferrin saturation) is between 10% and 50%. Because
of its short half-life, transferrin values decrease more quickly in protein malnutrition states and should be taken into consideration while
evaluating iron-deficiency states

QR CODE

. Page 4 of 11
 Name of Patient : Mr. HEERA BHATT Test Request ID : 30272509120003
Age/Gender : 60 Yrs/Male Specimen Drawn ON : 12-Sep-2025 09:34AM
Collected AT : NAAGRAJA DIAGNOSTICS Specimen Received ON : 12-Sep-2025 09:35AM
Referred BY : Dr. self Report DATE : 12-Sep-2025 02:42PM
Sample Type : [Link] - F - SEP10947,Serum - SEP10945, - ,EDTA Blood - SEP10946
Ref Customer :

Test Name Result Biological Reference Method

Range
Kidney Function Test (KFT )C.S.T
Urea 68.0 13.0-43.0 mg/dl Urease Colorimetric
Creatinine 2.20 0.70-1.40 mg/dL Jaffe Kinetic
Uric Acid 2.6 4.40-7.60 mg/dl Uricase Colorimetric
Calcium 8.80 8.5-10.5 mg/dl
Phosphorus 4.18 2.50-5.00 mg/dL Ammonium molybdate
UV
Sodium (NA+) 133.60 135.0-145.0 mmol/L Ion Selective Electrode
Potassium (K+) 3.75 3.50-5.50 mmol/L Ion Selective Electrode
Chloride 100.60 98.0-109.0 mmol/L Spectrophotometry
Bun / Creatinine Ratio 14.45 0.0-23.0 Calculated
Blood Urea Nitrogen (BUN) 31.78 6.00-20.0 mg/dl Spectro-photometry
Urea / Creatinine Ratio 30.91 24-48 Calculated

QR CODE

. Page 5 of 11
 Name of Patient : Mr. HEERA BHATT Test Request ID : 30272509120003
Age/Gender : 60 Yrs/Male Specimen Drawn ON : 12-Sep-2025 09:34AM
Collected AT : NAAGRAJA DIAGNOSTICS Specimen Received ON : 12-Sep-2025 09:35AM
Referred BY : Dr. self Report DATE : 12-Sep-2025 12:32PM
Sample Type : [Link] - F - SEP10947,Serum - SEP10945, - ,EDTA Blood - SEP10946
Ref Customer :

Test Name Result Biological Reference Range Method

IMMUNOASSAY
THYROID PROFILE
Triiodothyronine Total (T3) 1.36 0.81-1.81 ng/mL Electrochemiluminescence
immunoassay (ECLIA)
Thyroxine Total (T4) 10.2 4.85-15.6 ug/dL Electrochemiluminescence
immunoassay (ECLIA)
TSH (4th Generation) 1.71 0.38-5.00 uIU/mL Electrochemiluminescence
immunoassay (ECLIA)

PREGNANCY REFERENCE RANGE for TSH IN uIU/mL (As per American Thyroid Association.)
1st Trimester 0.10-2.50 uIU/mL
2nd Trimester 0.20-3.00 uIU/mL
3rd Trimester 0.30-3.00 uIU/mL
INTERPRETATION-
1. Primary hyperthyroidism is accompanied by elevated serum T3 & T4 values along with depressed TSH level.
2 .Primary hypothyroidism is accompanied by depressed serum T3 and T4 values & elevated serum TSH levels.
3. Normal T4 levels accompanied by high T3 levels and low TSH are seen in patients with T3 thyrotoxicosis.
4. Normal or low T3 & high T4 levels indicate T4 thyrotoxicosis ( problem is conversion of T4 to T3)
5. Normal T3 & T4 along with low TSH indicate mild / subclinical HYPERTHYROIDISM .
6. Normal T3 & low T4 along with high TSH is seen in HYPOTHYROIDISM .
7. Normal T3 & T4 levels with high TSH indicate Mild / Subclinical HYPOTHYROIDISM .
8. Slightly elevated T3 levels may be found in pregnancy and in estrogen therapy while depressed levels may be encountered in severe illness , malnutrition ,
renal failure and during therapy with drugs like propanolol.
9. Although elevated TSH levels are nearly always indicative of primary hypothroidism . rarely they can result from TSH secreting pituitary tumours ( seconday
hyperthyroidism )
*TSH IS DONE BY ULTRASENSITIVE 4th GENERATION CHEMIFLEX ASSAY*
COMMENTS:
Assay results should be interpreted in context to the clinical condition and associated results of other investigations. Previous treatment with corticosteroid
therapy may result in lower TSH levels while thyroid hormone levels are normal. Results are invalidated if the client has undergone a radionuclide scan within 7-
14 days before the test. Abnormal thyroid test findings often found in critically ill clients should be repeated after the critical nature of the condition is
[Link] production, circulation, and disintegration of thyroid hormones are altered throughout the stages of pregnancy.
Disclaimer-
TSH is an important marker for the diagnosis of thyroid [Link] studies have shown that the TSH distribution progressively shifts to a higher concentration with age ,and it is debatable
whether this is due to a real change with age or an increasing proportion of unrecognized thyroid diseasein the elderly.
TSH levels are subject to circardian variation,reaching peak levels between 2-4AM and ninimum between 6-10 PM. The variation is the order of 50% hence
time of the day has influence on the measures serum TSH [Link] and time of drug intake also influence the test result. r
Reference ranges are from Teitz fundamental of clinical chemistry 7th ed.

QR CODE

. Page 6 of 11
 Name of Patient : Mr. HEERA BHATT Test Request ID : 30272509120003
Age/Gender : 60 Yrs/Male Specimen Drawn ON : 12-Sep-2025 09:34AM
Collected AT : NAAGRAJA DIAGNOSTICS Specimen Received ON : 12-Sep-2025 09:35AM
Referred BY : Dr. self Report DATE : 12-Sep-2025 12:32PM
Sample Type : [Link] - F - SEP10947,Serum - SEP10945, - ,EDTA Blood - SEP10946
Ref Customer :

Test Name Result Biological Reference Method

Range
VITAMIN B12
Vitamin B12 Level 750.0 120-914 pg/mL Chemiluminescence
Immunoassay(CLIA)
Comments
Vitamin B12 along with folate is essential for DNA synthesis and myelin formation. Vitamin B12 deficiency can be because of nutritional deficiency,
malabsorption and other gastrointestinal causes. The test is ordered primarily to help diagnose the cause of macrocytic/ megaloblastic anemia.
Decreased levels are seen in: Increased levels are seen in:
anaemia, normal near term pregnancy, vegetarianism, partial
renal failure, hepatocelluar disorders,
gastrectomy/ ileal damage, celiac disease, with oral contraceptive
myeloproliferative disorders and at times with
use, parasitic competition, pancreatic deficiency, treated epilepsy,
excess supplementation of vitamins pills
smoking, hemodialysis and advancing age

QR CODE

. Page 7 of 11
 Name of Patient : Mr. HEERA BHATT Test Request ID : 30272509120003
Age/Gender : 60 Yrs/Male Specimen Drawn ON : 12-Sep-2025 09:34AM
Collected AT : NAAGRAJA DIAGNOSTICS Specimen Received ON : 12-Sep-2025 09:35AM
Referred BY : Dr. self Report DATE : 12-Sep-2025 12:32PM
Sample Type : [Link] - F - SEP10947,Serum - SEP10945, - ,EDTA Blood - SEP10946
Ref Customer :

Test Name Result Biological Reference Method

Range
VITAMIN D3 25-HYDROXY
Vitamin D, 25 Hydroxy 49.3 Deficiency<20 Enhanced
Sufficiency:20-65 Chemiluminescence
Intoxication:>70 ng/mL (Ultre Sensitive 4th
Generation Chemiflex)

Lower-than-normal levels suggest a vitamin D deficiency. This condition can result from Lack of exposure to sunlight,Lack of adequate vitamin D in the diet,
Liver and kidney diseases and Malabsorption. A vitamin D deficiency may lead to: *Low blood calcium levels (hypocalcaemia) *Thin or weak bones (rickets,
osteoporosis and osteomalacia) *High levels of parathyroid hormone (secondary hyperparathyroidism) Total 25-hydroxyvitamin D (D2 + D3) is the correct
measure of Vitamin D [Link]-than-normal levels suggest excess vitamin D, a condition called hypervitaminosis D. It is usually caused by vitamin D in the
form of doctor-prescribed dietary supplements. 95% of serum vitamin D is Vit D3. D2 is only received from supplements.

QR CODE

. Page 8 of 11
 Name of Patient : Mr. HEERA BHATT Test Request ID : 30272509120003
Age/Gender : 60 Yrs/Male Specimen Drawn ON : 12-Sep-2025 09:34AM
Collected AT : NAAGRAJA DIAGNOSTICS Specimen Received ON : 12-Sep-2025 09:35AM
Referred BY : Dr. self Report DATE : 12-Sep-2025 10:22AM
Sample Type : [Link] - F - SEP10947,Serum - SEP10945, - ,EDTA Blood - SEP10946
Ref Customer :

Test Name Result Biological Reference Method

Range
HAEMATOLOGY
COMPLETE BLOOD COUNT(CBC)23
R.B.C 4.32 4.5-5.5 Millions/cumm Impedance variation
Haemoglobin 14.2 13.0-17.0 g/dl Spectrophotometry
Packed Cell Volume 40.40 40.0-50.0 % Analogical Integration
MCV 93.5 83-101 fL Calculated
MCH 32.8 27.0-32.0 pg Calculated
MCHC 35.1 27.0-48.0 g/dL Calculated
RDW-CV 15.2 11.5-14.0 % Calculated
Platelet Count 150 150-410 1000/uL Impedance Variation
Total WBC Count 9300 4000-10000 /cumm Impedance Variation
MPV 10.50 9.1-11.9 % Calculated
PCT 0.15 0.18-0.39 % Calculated
PDW 14.80 11.0-22.0 % Calculated
Differential Leucocyte Count
Neutrophil 67 40.0-80.0 % flow cytometry/manual
Lymphocyte 23 20.0-40.0 % flow cytometry/manual
Monocytes 06 2-10 % flow cytometry/manual
Eosinophils 04 01-06 % Flow cytometry/manual
Basophils 00 0-1 % Flow cytometry/manual
Absolute Neutrophils 6.23 2.00-7.00 10^3/µL
Absolute Lymphocytes 2.14 1.00-3.00 10^3/µL
Absolute Monocytes 0.56 0.20-1.00 10^3/µL
Absolute Eosinophils 0.37 0.02-0.50 10^3/µL
Neutrophil - Lymphocyte Ratio (NLR) 2.91 % Calculated
Lymphocyte - Monocyte Ratio (LMR) 3.83 % Calculated
Platelet - Lymphocyte Ratio (PLR) 6.52 % Calculated

QR CODE

. Page 9 of 11
 Name of Patient : Mr. HEERA BHATT Test Request ID : 30272509120003
Age/Gender : 60 Yrs/Male Specimen Drawn ON : 12-Sep-2025 09:34AM
Collected AT : NAAGRAJA DIAGNOSTICS Specimen Received ON : 12-Sep-2025 09:35AM
Referred BY : Dr. self Report DATE : 12-Sep-2025 11:50AM
Sample Type : [Link] - F - SEP10947,Serum - SEP10945, - ,EDTA Blood - SEP10946
Ref Customer :

Test Name Result Biological Reference Method

Range
Erythrocyte Sedimentation Rate (ESR) 20 0-20 mm/h Westergren

QR CODE

. Page 10 of 11
 Name of Patient : Mr. HEERA BHATT Test Request ID : 30272509120003
Age/Gender : 60 Yrs/Male Specimen Drawn ON : 12-Sep-2025 09:34AM
Collected AT : NAAGRAJA DIAGNOSTICS Specimen Received ON : 12-Sep-2025 09:35AM
Referred BY : Dr. self Report DATE : 12-Sep-2025 11:50AM
Sample Type : [Link] - F - SEP10947,Serum - SEP10945, - ,EDTA Blood - SEP10946
Ref Customer :

Test Name Result Biological Reference Method

Range
HbA1c (ngsp) 5.80 HPLC
Diagnosing Diabetes >= 6.5
%
HbA1c (IFCC) 39.7 mmol/mol HPLC
Estimated Average Glucose 119.7 mg/dl
Interpretation:
As per American Diabetes Association (ADA)
Reference Group HbA1c in %
Non diabetic adults >=18 years <5.7
At risk (Prediabetes) 5.7 - 6.4
Diagnosing Diabetes >= 6.5Note:

1, Since HbA1c reflects long term fluctuations in the blood glucose concentration, a diabetic patient who is recently under good control may still
have a high concentration of HbA1c. Converse is true for a diabetic previously under good control but now poorly controlled.

2. Target goals of < 7.0 % may be beneficial in patients with short duration of diabetes, long life expectancy and no significant cardiovascular
disease. In patients with significant complications of diabetes, limited life expectancy or extensive co-morbid conditions, targeting a goal of < 7.0
% may not be appropriate.

Comment: HBA1c provides an index of average blood glucose levels over the past 8 - 12 weeks and is a much better indicator of long term
glycemic control as compared to blood and urinary glucose determinations.

*** End Of Report ***

QR CODE

. Page 11 of 11